Friday, November 21, 2008

You are here: Home > Clinical Trials & Research > Genitourinary Cancer

Genitourinary Cancer

CALGB-90203 Lead group: CALGB
A Randomized Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer
E2805 (ASSURE) Lead group: ECOG
Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma

We participate in many NCI sponsored trials. Please feel free to contact Leann Ross at (304) 399-6617 or leann.ross@chhi.org or Barbara Payne at (304) 399-6637.

For more information about the clinical trials listed please go to http://www.clinicaltrials.gov.

Page last updated: 05/06/2008  |  Recommend this page  |  Printer friendly version